Abstract 412: Pentaerithrityltetranitrate Does Not Deteriorate Endothelial Dysfunction In Patients With Coronary Artery Disease. A Prospective, Randomized, Double-blind, Placebo-controlled, Monocentric Clinical Trial (PENTA)